Explore Stanford technologies available for licensing:

Stanford researchers have developed the first ex vivo bone marrow niche capable of sustaining normal and diseased hematopoietic cells long-term.

Stanford inventors have discovered that applying a hydrogel containing an inhibitor of mechanotransduction pathways on top of a skin graft reduces scarring and promotes healing after repair of traumatic injuries like severe burn wounds.